VeriMomtipa-lauroyl sarcosinate hamilelikte güvenli mi?
Authoritative dossiers for lauroyl/sarcosinate category members (representative: sodium N‑lauroylsarcosinate) include an OECD 414 prenatal developmental study and long‑term reproductive/2‑year studies reporting no developmental/reproductive effects at doses up to and including high NOAELs; there is no harmonised CLP reproductive classification (ECHA registration dossiers show no H360/H361). PubMed/peer‑reviewed work on lauroyl sarcosinate does not identify reproductive/teratogenic effects. (Sources: ECHA registration dossiers; OECD414 summary in registration; PubMed literature.)
Pregnancy-safe products containing tipa-lauroyl sarcosinate
Related ingredients
Frequently asked questions
- tipa-lauroyl sarcosinate hamilelikte güvenli mi?
- Authoritative dossiers for lauroyl/sarcosinate category members (representative: sodium N‑lauroylsarcosinate) include an OECD 414 prenatal developmental study and long‑term reproductive/2‑year studies reporting no developmental/reproductive effects at doses up to and including high NOAELs; there is no harmonised CLP reproductive classification (ECHA registration dossiers show no H360/H361). PubMed/peer‑reviewed work on lauroyl sarcosinate does not identify reproductive/teratogenic effects. (Sources: ECHA registration dossiers; OECD414 summary in registration; PubMed literature.)
- tipa-lauroyl sarcosinate emzirirken güvenli mi?
- No evidence in registration dossiers or peer‑reviewed literature that lauroyl sarcosinates cause reproductive or lactation hazards or have mechanisms that would predict milk transfer or developmental toxicity. With topical cosmetic use (primarily rinse‑off surfactant), systemic exposure is expected to be negligible. (Sources: ECHA registration summaries; PubMed literature.)
- tipa-lauroyl sarcosinate bebek cildi için güvenli mi?
- The ingredient is a mild anionic surfactant used in cleansers; authoritative safety dossiers for lauroyl sarcosinates support cosmetic use and do not indicate intrinsic developmental/reproductive hazard. For baby skin (0–3 yr) increase exposure score by +1 because infant skin has an immature barrier and higher surface‑area‑to‑weight, so low but measurable dermal absorption from rinse‑off/wash products is plausible even when adult systemic exposure is negligible. There is some consumer guidance and EWG notes about nitrosamine contamination risk for this class (cosmetic formulation/contaminant concern), but not reproductive toxicity. (Sources: ECHA registration summaries; CosIng/Cosmetic ingredient listings; EWG notes.)
- VeriMom tipa-lauroyl sarcosinate nasıl puanlıyor?
- VeriMom tipa-lauroyl sarcosinate'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte tipa-lauroyl sarcosinate yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.